Immunologic aspects of osteoporosis
Tài liệu tham khảo
Manolagas, 1995, Bone marrow, cytokines, and bone remodelling. Emerging insights into the pathophysiology of osteoporosis, N. Engl. J. Med., 332, 305, 10.1056/NEJM199502023320506
Horowitz, 1993, Cytokines and estrogen in bone: Anti-osteoporotic effects, Science, 260, 626, 10.1126/science.8480174
Cummings, 1985, Epidemiology of osteoporosis and osteoporotic fractures, Epidemiol. Rev., 7, 178, 10.1093/oxfordjournals.epirev.a036281
Riggs, 1995, The worldwide problem of osteoporosis: insights afforded by epidemiology, Bone, 17, 505S, 10.1016/8756-3282(95)00258-4
Christiansen, 1993, Skeletal osteoporosis, J. Bone Miner. Res., 8, S475, 10.1002/jbmr.5650081308
Orwoll, 1995, Osteoporosis in men, Endocrine Rev., 16, 87, 10.1210/edrv-16-1-87
Kelepouris, 1995, Severe osteoporosis in men, Ann. Int. Med., 123, 452, 10.7326/0003-4819-123-6-199509150-00010
Bendavid, 1996, Factors associated with bone mineral density in middle-aged men, J. Bone Miner. Res., 11, 1185, 10.1002/jbmr.5650110818
Gunby, 1994, Epidemiology of bone loss with aging, Clin. Geriatr. Med., 10, 557, 10.1016/S0749-0690(18)30316-1
Chrischilles, 1991, A model of lifetime osteoporosis impact, Arch. Int. Med., 151, 2026, 10.1001/archinte.151.10.2026
Melton, 1996, Epidemiology of hip fractures: implications of the exponential increase with age, Bone, 18, 121S, 10.1016/8756-3282(95)00492-0
Kannus, 1996, Epidemiology of hip fractures, Bone, 18, 57S, 10.1016/8756-3282(95)00381-9
White, 1987, Rate of mortality for elderly patients after fractures of the hip in the 1980's, J. Bone Joint Surgery, 69A, 1335
Fitzgerald, 1988, The care of elderly patients with hip fractures. Changes since implementation of the prospective payment system, N. Engl. J. Med., 319, 1392, 10.1056/NEJM198811243192106
Seeman, 1995, The dilemma of osteoporosis in men, Am. J. Med., 98, 76S, 10.1016/S0002-9343(05)80082-8
Jackson, 1990, Osteoporosis in men: Diagnosis, pathophysiology, and prevention, Medicine, 69, 137, 10.1097/00005792-199005000-00002
Nguyen, 1996, Risk factors for osteoporotic fractures in elderly men, Am. J. Epidemiol., 144, 255, 10.1093/oxfordjournals.aje.a008920
Jones, 1996, Prevalent vertebral deformities: relationship to bone mineral density and spinal osteophytosis in elderly men and women, Osteoporos. Int., 6, 233, 10.1007/BF01622740
Resch, 1995, Risk of vertebral fractures in men: relationship to mineral density of the vertebral body, Am. J. Roentgenol., 164, 1447, 10.2214/ajr.164.6.7754890
Krall, 1997, Bone mineral density and biochemical markers of bone turnover in healthy elderly men and women, J. Gerontol., 52A, M61, 10.1093/gerona/52A.2.M61
Edwards, 1994, Age-related osteoporosis, Clin. Geriatr. Med., 10, 575, 10.1016/S0749-0690(18)30317-3
Parfitt, 1995, Relations between histoloic indices of bone formation: Implications for the pathogenesis of spinal osteoporosis, J. Bone Miner. Res., 10, 466, 10.1002/jbmr.5650100319
Lips, 1978, Mean wall thickness of trabecular bone packets in the human iliac crest: Changes with age, Calcif. Tissue Int., 26, 13, 10.1007/BF02013227
Recker, 1988, Static and tetracycline-based bone histomorphometric data from 34 normal postmenopausal females, J. Bone Miner. Res., 3, 133, 10.1002/jbmr.5650030203
Okamoto, 1995, Femoral peak bone mass and osteoclast number in an animal model of age-related spontaneous osteopenia, Anat. Record, 242, 21, 10.1002/ar.1092420104
Jilka, 1996, Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence, J. Clin. Invest., 97, 1732, 10.1172/JCI118600
Kahn, 1995, Age-related bone loss, Clin. Orth. Rel. Res., 313, 69
Matayoshi, 1996, Generation of human osteoclasts from peripheral blood hematopoietic precursors cells in absence of stromal cells: Effects of estrogen and aging, J. Bone Miner. Res., 11, S282
Suda, 1995, Modulation of osteoclast differentiation by local factors, Bone, 17, 87S, 10.1016/8756-3282(95)00185-G
Felix, 1995, Cytokine production by calvariae of osteopetrotic mice, Bone, 17, 5, 10.1016/8756-3282(95)00130-6
Morohashi, 1994, Macrophage colony-stimulating factor restores bone resorption in op/op bone in vitro in conjunction with parathyroid hrmone or 1,25-dihydroxyvitamin D3, J. Bone Miner. Res., 9, 401, 10.1002/jbmr.5650090316
hilippart, 1993, Immune cell defects affect bone remodelling in osteoporotic op/op mice, Bone Miner., 23, 317, 10.1016/S0169-6009(08)80106-7
Blackman, 1988, Comparison of the effects of lung cancer, benign lung disease, and normal aging on pituitary-gonadal function in men, J. Clin. Endocrinol. Metab., 66, 88, 10.1210/jcem-66-1-88
Harman, 1980, Reproductive hormones in aging men. I. Measurement of sex steroids, basal luteinizing hormone and Leydig cell response to human chorionic gonadotropin, J. Clin. Endocrinol. Metab., 51, 35, 10.1210/jcem-51-1-35
Nieschlag, 1982, Reproductive function in young fathers and grandfathers, J. Clin. Endocrinol. Metab., 51, 675
Vermeulen, 1991, Clinical review 24: Androgens in the aging male, J. Clin. Endocrinol. Metab., 73, 221, 10.1210/jcem-73-2-221
Tenover, 1987, The effects of aging in normal men on bioavailable testosterone and luteinizing hormone secretion: Response to clomiphene citrate, J. Clin. Endocrinol. Metab., 65, 1118, 10.1210/jcem-65-6-1118
Nankin, 1986, Decreased bioavailable testosterone in aging normal and impotent men, J. Clin. Endocrinol. Metab., 63, 1418, 10.1210/jcem-63-6-1418
Nahoul, 1990, Age related decline of plasma bioavailable testosterone in adult men, J. Steroid Biochem. Molec. Biol., 35, 293, 10.1016/0022-4731(90)90287-3
Corpas, 1993, Human growth hormone and human aging, Endocrine Reviews, 14, 20, 10.1210/edrv-14-1-20
Finkelstein, 1972, Age-related changes in the twenty-four hour spontaneous secretion of growth hormone in normal individuals, J. Clin. Endocrinol. Metab., 35, 665, 10.1210/jcem-35-5-665
Zadik, 1985, The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals, J. Clin. Endocrinol. Metab., 60, 513, 10.1210/jcem-60-3-513
Ho, 1987, Effects of sex and age on 24-hour profile of growth hormone secretion in men: Importance of endogenous estradiol concentrations, J. Clin. Endocrinol. Metab., 64, 51, 10.1210/jcem-64-1-51
Vermeulen, 1987, Nyctohemoral growth hormone profiles in young and aged men: Correlations with somatomedin-C levels, J. Clin. Endocrinol. Metab., 64, 884, 10.1210/jcem-64-5-884
Corpas, 1992, GHRH 1–29 twice daily reverses the decreased GH and IGFI levels in old men, J. Clin. Endocrinol. Metab., 75, 530, 10.1210/jc.75.2.530
Lang, 1987, Effects of sex and age on growth hormone response to growth hormone releasing hormone in healthy individuals, J. Clin. Endocrinol. Metab., 65, 535, 10.1210/jcem-65-3-535
Bellantoni, 1991, Effects of progestin-opposed transdermal estrogen administration on GH and IGF-I in postmenopausal women of different ages, J. Clin. Endocrinol. Metab., 72, 172, 10.1210/jcem-72-1-172
Shibasaki, 1984, Age-related changes in plasma growth hormone response to growth hormone-releasing factor in man, J. Clin. Endocrinol. Metab., 58, 212, 10.1210/jcem-58-1-212
Iovino, 1989, Repetitive growth hormone-releasing hormone administration restores the attenuated growth hormone (GH) response to GH releasing hormone testing in normal aging, J. Clin. Endocrinol. Metab., 69, 910, 10.1210/jcem-69-4-910
Coiro, 1991, Restoration of normal growth hormone responsiveness to GHRH in normal aged men by infusion of low amounts of theophylline, J. Gerontol., 46, M155, 10.1093/geronj/46.5.M155
Corpas, 1993, Continuous subcutaneous infusions of GHRH 1–44 for 14 days increase GH and IGF-I levels in old men, J. Clin. Endocrinol. Metab., 76, 134, 10.1210/jc.76.1.134
Pavlov, 1986, Responses of growth hormone and somatomedin-C to GHreleasmg hormone in healthy aging men, J. Clin. Endocrinol. Metab., 62, 595, 10.1210/jcem-62-3-595
Seeman, 1983, Risk factors for spinal osteoporosis in men, Am. J. Med., 75, 977, 10.1016/0002-9343(83)90878-1
Jackson, 1990, Osteoporosis in men: diagnosis, pathophysiology, and prevention, Medicine, 69, 137, 10.1097/00005792-199005000-00002
Francis, 1989, Spinal osteoporosis in men, Bone Miner., 5, 347, 10.1016/0169-6009(89)90012-3
Stanley, 1991, Does hypogonadism contribute to the occurrence of minimal trauma hip fracture in elderly men?, J. Am. Geriatr. Soc., 39, 766, 10.1111/j.1532-5415.1991.tb02698.x
Nachtigall, 1979, Estrogen replacement therapy I: A 10-year study in the relationship to osteoporosis, Obstetr. Gynecol., 53, 277
Prince, 1991, Prevention of postmenopausal osteoporosis. A comparative study of exercise, calcium supplementation, and hormone-replacement therapy, N. Engl. J. Med., 325, 1189, 10.1056/NEJM199110243251701
Quigley, 1987, Estrogen therapy arrests bone loss in elderly women, Am. J. Obstetr. Gynecol., 156, 1516, 10.1016/0002-9378(87)90025-1
Ettinger, 1985, Long-term estrogen replacement therapy prevents bone loss and fractures, Ann. Intern. Med., 102, 319, 10.7326/0003-4819-102-3-319
Weiss, 1980, Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen, N. Engl. J. Med., 303, 1195, 10.1056/NEJM198011203032102
Cauley, 1995, Estrogen replacement therapy and fractures in older women, Ann. Intern. Med., 122, 9, 10.7326/0003-4819-122-1-199501010-00002
Finkelstein, 1989, Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism, J. Clin. Endocrinol. Metab., 69, 776, 10.1210/jcem-69-4-776
Diamond, 1991, Effects of testosterone and venesection on spinal and peripheral bone mineral in six hypogonadal men with hemochromatosis, J. Bone Miner. Res., 6, 39, 10.1002/jbmr.5650060108
Isaia, 1992, Effect of testosterone on bone in hypogonadal males, Maturitas, 15, 47, 10.1016/0378-5122(92)90061-8
Devogelaer, 1992, Low bone mass in hypogonadal males. Effect of testosterone substitution therapy, a densitometric study, Maturitas, 15, 17, 10.1016/0378-5122(92)90057-B
Bertelloni, 1995, Short-term effect of testosterone treatment on reduced bone density in boys with constitutional delay of puberty, J. Bone Miner. Res., 10, 1488, 10.1002/jbmr.5650101009
Wang, 1996, Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men-a clinical research center study, J. Clin. Endocrinol. Metab., 81, 3654, 10.1210/jc.81.10.3654
Jackson, 1987, Bone histomorphometry in hypogonadal and eugonadal men with spinal osteoporosis, J. Clin. Endocrinol. Metab., 65, 53, 10.1210/jcem-65-1-53
Rosen, 1993, Reduced bone mineral content in adult patients with growth hormone deficiency, Acta Endocrinol. (K.bh), 129, 201, 10.1530/acta.0.1290201
O'Halloran, 1993, Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency, J. Clin. Endocrinol. Metab., 76, 1344, 10.1210/jc.76.5.1344
Johannson, 1996, Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency, J. Clin. Endocrinol. Metab., 81, 2865, 10.1210/jc.81.8.2865
Rudman, 1990, Effect of human growth hormone in men over 60 years old, N. Engl. J. Med., 323, 1, 10.1056/NEJM199007053230101
Holloway, 1994, Effects of recombinant human growth hormone on metabolic indices,body composition, and bone turnover in healthy elderly women, J. Clin. Endocrinol. Metab., 79, 470, 10.1210/jc.79.2.470
Murasko, 1990, T cell function in aging: Mechanisms of decline, Ann. Rev. Gerontol. Geriatr., 10, 71
Chopra, 1989, Interleukin 2, interleukin 2 receptor and interferon g synthesis and mRNA expression in phorbol myrisate acetate and calcium ionophore A23187 stimulated T cells from elderly humans, Clin. Immunol. Immunopathol., 53, 297, 10.1016/0090-1229(89)90058-5
Tang, 1991, Age-associated increase in interleukin 6 in MRL/lpr mice, Int. Immunol., 3, 273, 10.1093/intimm/3.3.273
Suzuki, 1993, Serum soluble interleukin-6 receptor in MRL/ lpr mice is elevated with age and mediates the interleukin-6 signal, Eur. J. Immunol., 23, 1078, 10.1002/eji.1830230515
Effros, 1991, Influence of age and caloric restriction on macrophage IL-6 and TNF production, Lymphokine Cytokine Res., 10, 347
Zhou, 1993, Increased production of TGF-beta and IL-6 by aged spleen cells, Immunology Letters, 36, 7, 10.1016/0165-2478(93)90061-6
Foster, 1992, Fever, tumor necrosis factor, and interlukin-6 in young, mature, and aged Fischer 344 rats, Am. J. Physiol., 262, R211
Wei, 1992, Increase of plasma IL-6 concentration with age in healthy subjects, Life Sciences, 51, 1953, 10.1016/0024-3205(92)90112-3
Goya, 1992, In vivo effects of growth hormone on thymus function in aging mice, Brain Behav. Immunol., 6, 341, 10.1016/0889-1591(92)90033-K
Daynes, 1993, Altered regulation of IL-6 production with normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative, J. Immunol., 150, 5219, 10.4049/jimmunol.150.12.5219
Ershler, 1993, Interleukin-6 and aging: blood levels and mononuclear cell production increase with advancing age and in vitro production is modifiable by dietary restriction, Lymphokine Cytokine Res., 12, 225
Sindermann, 1993, Investigations of the lymphokine system in elderly individuals, Mech. Ageing Dev., 70, 149, 10.1016/0047-6374(93)90066-Z
McKane, 1993, Effect of age and menopause on serum interleukin-6 levels in women, J. Bone Miner. Res., 8, S157
Fagiolo, 1993, Increased cytokine production in mononuclear cells of healthy elderly people, Eur. J. Immunol., 23, 2375, 10.1002/eji.1830230950
Liao, 1993, Increased urinary cytokines in the elderly, Aging Immunol. Infect. Dis., 4, 139
Kania, 1995, Elevated plasma levels of interleukin-6 in postmenopausal women do not correlate with bone density, J. Am. Geriatr. Soc., 43, 236, 10.1111/j.1532-5415.1995.tb07328.x
Bellido, 1991, Demonstration of estrogen receptors by western blot analysis in bone marrow stromal cells and osteoblasts: Correlation with interleukin-6 regulation by estrogens and antiestrogens, J. Bone Miner. Res., 6, S88
Girasole, 1992, 17β-Estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: A potential mechanism for the antiosteoporotic effect of estrogens, J. Clin. Invest., 89, 883, 10.1172/JCI115668
Girasole, 1992, Upregulation of osteoclastogenic potential of the marrow is induced by orchiectomy and is reversed by testosterone replacement in the mouse, J. Bone Miner. Res., 7, 596
Passeri, 1991, 17β estradiol regulates IL-6 production and osteoclast development in murine calvaria cell cultures, J. Bone Miner. Res., 6, S263
Jilka, 1992, Increased osteoclast development after estrogen loss: Mediation by interleukin-6, Science, 257, 88, 10.1126/science.1621100
Keller, 1996, Inhibition of NFκB activity through maintenance of IkBa levels contributes to dihydrotestosterone-mediated repression of the interleukin-6 promoter, J. Biol. Chem., 271, 26267, 10.1074/jbc.271.42.26267
Kishimoto, 1992, IL-6 receptor and mechanism of signal transduction, Int. J. Immunopharmac., 14, 431, 10.1016/0192-0561(92)90173-I
Taga, 1993, Cytokine receptors and signal transduction, FASEB J., 7, 3387
Novick, 1989, Soluble cytokine receptors are present in normal human urine, J. Expl. Med., 170, 1409, 10.1084/jem.170.4.1409
Lorenzo, 1991, The role of cytokines in the regulation of local bone resorption, Crit. Rev. Immunol., 11, 195
Bellido, 1994, Sex steroids regulate the expression of the gp130 transduction pathway by bone marrow and bone cells, Bone Miner., 25, S39
Fang, 1991, Effects of interleukin-6 on cellular function in UMR-106-01 osteoblast-like cells, J. Bone Miner. Res., 6, 133, 10.1002/jbmr.5650060206
Taguchi, 1996, Interleukin-6 induces osteoblast differentiation in uncommitted embryonic fibroblasts (EF) (Abs.), J. Bone Miner. Res., 11, S101
Ishimi, 1990, IL-6 is produced by osteoblasts and induces bone resorption, J. Immunol., 145, 3297, 10.4049/jimmunol.145.10.3297
Green, 1994, Interleukin-6 attenuates agonist-mediated calcium mobilization in murine osteoblastic cells, J. Clin. Invest., 93, 2340, 10.1172/JCI117239
Littlewood, 1991, Human osteoblastlike cells do not respond to interleukin-6, J. Bone Miner. Res., 6, 141, 10.1002/jbmr.5650060207
Feyen, 1989, Interleukin-6 is produced by bone and modulated by parathyroid hormone, J. Bone Miner. Res., 4, 633, 10.1002/jbmr.5650040422
Greenfield, 1993, In vitro PTH increases both mRNA expression and IL-6 secretion from both osteoblast like cells and rat osteoblasts, J. Bone Miner. Res., 8, 1163, 10.1002/jbmr.5650081003
Löwik, 1989, Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: A possible role of interleukin-6 in osteoclastogenesis, Biochem. Biophys. Res. Comm., 162, 1546, 10.1016/0006-291X(89)90851-6
Rahman, 1992, Bradykinin stimulates the production of prostaglandin E2 and interleukin-6 in human osteoblast-like cells, Biochim. Biophys. Acta, 1135, 97, 10.1016/0167-4889(92)90172-8
Zheng, 1994, Recombinant human bone morphogenetic protein-2 enhances expression of interleukin-6 and transforming growth factor-b1 genes in normal human osteoblast-like cells, J. Cell Physiol., 159, 76, 10.1002/jcp.1041590111
Al-Humidan, 1991, Interleukin-6 does not stimulate bone resorption in neonatal mouse calvariae, J. Bone Miner. Res., 6, 3, 10.1002/jbmr.5650060103
Flanagan, 1995, The effect of interleukin-6 and soluble interleukin-6 receptor protein on the bone resorptive activity of human osteoclasts generated in vitro, J. Pathol., 176, 289, 10.1002/path.1711760311
Kurihara, 1990, IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release, J. Immunol., 144, 4226, 10.4049/jimmunol.144.11.4226
Tamura, 1993, Soluble interleukin-6 receptor triggers osteoclast formation by interleukin-6, 90, 11924
Roodman, 1992, Interleukin-6: a potential autocrine/ paracrine factor in Paget's disease of bone, J. Clin. Invest., 89, 46, 10.1172/JCI115584
Black, 1991, Interleukin-6 causes hypercalcemia in vivo, and enhances the bone resorbing potency of interleukin-1 and tumor necrosis factor by two orders of magnitude in vitro, J. Bone Miner. Res., 6, S271
Girasole, 1992, 17β-Estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens, J. Clin. Invest., 89, 883, 10.1172/JCI115668
Ohsaki, 1992, Evidence for an autocrine/paracrine role for interleukin-6 in bone resorption by giant cells from giant cell tumors of bone, Endocrinology, 131, 2229, 10.1210/en.131.5.2229
Bellido, 1995, Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor, J. Clin Invest., 95, 2886, 10.1172/JCI117995
Poli, 1994, Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion, EMBO, 13, 1189, 10.1002/j.1460-2075.1994.tb06368.x
Wong, 1988, ultiple actions of interleukin-6 within a cytokine network, Immunol. Today, 9, 137, 10.1016/0167-5699(88)91200-5
Bataille, 1991, Letter to the editor The bone-resorbing activity of interleukin-6, J. Bone Miner. Res., 6, 1143, 10.1002/jbmr.5650061017
Gowen, 1991, Reply: The bone-resorbing activity of interleukin-6 J, J. Bone Miner. Res., 6, 1145, 10.1002/jbmr.5650061018
Roodman, 1992, Perspectives Interleukin-6: An osteotrophic factor?, J. Bone Miner. Res., 7, 475, 10.1002/jbmr.5650070502
Ralston, 1994, Analysis of gene expression in human bone biopsies by polymerase chain reaction: Evidence for enhanced cytokine expression in postmenopausal osteoporosis, J. Bone Min. Res., 9, 883, 10.1002/jbmr.5650090614
Zhang, J.; Keller, E.; Stehler, B.; Ershler, W. B. Orchiectomy increases bone marrow interleukin-b expression in mice. Calcified Tissue International (In press).